Fundz

Imaginab Completes $12.8 Million Financing To Accelerate Growth Plans

PRIVATEJun 03, 2021

Amount Raised

$12.8 Million

Round Type

Funding Round

InglewoodBiotechnology

Description

ImaginAb Inc, a leading biotechnology company focused on developing next generation radiopharmaceutical imaging and therapy agents, has secured an additional $12.8 million in growth capital.

Quick answer

ImaginAb raised $12.8 Million in a Funding Round round, dated June 3, 2021. ImaginAb is based in Inglewood, California, United States.

How much did ImaginAb raise?
ImaginAb raised $12.8 Million in a Funding Round round on June 3, 2021.
What does ImaginAb do?
ImaginAb, Inc. is an antibody engineering company that specializes in the development of novel and proprietary biologics technology platforms for therapeutic and diagnostic applications.
Where is ImaginAb based and how big is it?
ImaginAb is based in Inglewood, California, United States. Fundz records about 510 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ImaginAb that raised within 45 days of this round, from Fundz verified event records.

  • Cognos Therapeutics Inc raised $600K (Seed) on July 16, 2021.
  • LungLife AI, Inc. raised $1.1M (Seed) on July 16, 2021.
  • OM1 raised $85M (Funding Round) on July 16, 2021.
  • Tellus Therapeutics raised $2M (Seed) on July 16, 2021.
  • Samsara Therapeutics Inc. raised $10M on July 16, 2021.
  • LungLife AI, Inc. raised $6.1M on July 16, 2021.

Who to call at ImaginAb, and when

A new round usually means ImaginAb is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ImaginAb raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImaginAb, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImaginAb. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImaginAb

Location

423 HINDRY AVENUE

Inglewood, California, United States

About

ImaginAb, Inc. is an antibody engineering company that specializes in the development of novel and proprietary biologics technology platforms for therapeutic and diagnostic applications. The company's expertise lies in engineering small antibody formats that enable highly specific cancer targeting, rapid tumor uptake, and blood clearance, making them highly effective for imaging and treating tumors with a broad range of radioisotopes, particularly alpha emitters.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImaginAb raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ImaginAb's next move

See what Strategic adds

ImaginAb raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.